Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

MVZ Dr. Kasche und Kollegen GmbH

Research site

Germany Langelohstraße 158, 22549 Hamburg, Germany

  • Conjunctivitis allergic · Seasonal allergy · Hidradenitis
  • Adults and children

About Specializations

MVZ Dr. Kasche und Kollegen GmbH in Hamburg, Germany specialises in clinical trials of conditions such as Conjunctivitis allergic, Seasonal allergy, Hidradenitis, Rhinitis allergic, and other specialisations. This site conducts important research.

Main research areas of the site

Dermatology and Skin Disorders

The medical center is at the forefront of research in dermatology, focusing on innovative treatments for skin disorders. The center's commitment to advancing dermatological care is evident through its cutting-edge research and clinical trials.

  • Hidradenitis Suppurativa
  • Psoriasis
  • Eczema

By exploring new therapeutic options, the center aims to improve the quality of life for patients with chronic skin conditions, offering hope through groundbreaking research and personalized care strategies.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Langelohstraße 15822549 HamburgGermany
Open in maps ↗
Recruiting now
no trials
Conditions studied
4

More sites in HamburgGermany

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

5 clinical trials

Conjunctivitis allergic+1

Not recruiting

Study on Mannan-Conjugated Birch Pollen Allergoids for Adolescents and Adults with Birch Pollen-Induced Allergic Rhinitis or Rhinoconjunctivitis

Investigational
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Betula Pendula Pollen Allergoid, Mannan-Conjugated, Polymerised
  • Sponsor:CCDRD Cooperative Clinical Drug Research and Development AG

Conjunctivitis allergic+1

Not recruiting

Dose‑finding trial of a mannan‑conjugated Phleum pratense/Dactylis glomerata allergoid vaccine in patients with grass‑pollen allergic rhinitis or rhinoconjunctivitis

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Bilastine
  • Sponsor:Inmunotek S.L.

Hidradenitis

Not recruiting

Study on the Effectiveness of IC0624 for Patients with Mild to Moderate Hidradenitis Suppurativa

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Sodium bituminosulfonate dry substance
  • Sponsor:Ichthyol-Gesellschaft Cordes Hermanni & Co. GmbH & Co. KG

Conjunctivitis allergic

Not recruiting

Study on the Safety and Effectiveness of Betula Pollen Extract for Children and Adolescents Aged 5-17 with Birch Pollen Allergies and Possible Asthma

Registered drug
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Betula Pollen Extract
  • Sponsor:Stallergenes

Conjunctivitis allergic+1

Not recruiting

Study on the Effects of Mannan-Conjugated Birch Pollen Allergoids for Adolescents and Adults with Birch Pollen-Induced Allergic Rhinitis or Rhinoconjunctivitis

Registered drug
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Bilastine
  • Sponsor:Inmunotek S.L.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.